Infectious Disease
Enterovirus
0
Pipeline Programs↗
1
Active Trials↗
1
Companies Involved↗
Enterovirus is an early-stage landscape with 0 programs across 1 company. The most active players are Sinovac Biotech Co., Ltd.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
12
clinical trials
Completed6 · 50%
Unknown status5 · 42%
Recruiting1 · 8%
Clinical Trials
Trial Activity
12 trials
Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine
Recruiting·IInstitute of Medical Biology, Chinese Academy of Medical Sciences·Phase 4·NCT06146088·1,500 enrolled
Immunity and Safety of Inactivated Enterovirus 71 Vaccine Post-marketing Among Children Aged 6-35 Months in China
Completed·Jiangsu Province Centers for Disease Control and Prevention·Phase 4·NCT03893747·3,000 enrolled
The Phase IVb of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Children
Completed·IInstitute of Medical Biology, Chinese Academy of Medical Sciences·Phase 4·NCT03001986·40,724 enrolled
Safety Study of Enterovirus 71 Vaccine in Children Aged 6-35 Months Old
Unknown status·BBeijing Chaoyang District Centre for Disease Control and Prevention·Phase 4·NCT02806531·20,000 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)